severe cold head congestion
Generic: acetaminophen, guaifenesin, and phenylephrine hydrochloride
Labeler: chain drug marketing associationDrug Facts
Product Profile
Brand Name
severe cold head congestion
Generic Name
acetaminophen, guaifenesin, and phenylephrine hydrochloride
Labeler
chain drug marketing association
Dosage Form
TABLET, COATED
Routes
Active Ingredients
acetaminophen 325 mg/1, guaifenesin 200 mg/1, phenylephrine hydrochloride 5 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
63868-081
Product ID
63868-081_2435ad4f-59a9-f2ac-e063-6394a90ae811
Product Type
HUMAN OTC DRUG
Marketing Category
OTC MONOGRAPH DRUG
Application Number
M012
Marketing Start
2015-09-30
Marketing End
2026-09-30
Pharmacologic Class
Established (EPC)
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
63868081
Hyphenated Format
63868-081
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
severe cold head congestion (source: ndc)
Generic Name
acetaminophen, guaifenesin, and phenylephrine hydrochloride (source: ndc)
Application Number
M012 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 325 mg/1
- 200 mg/1
- 5 mg/1
Packaging
- 2 BLISTER PACK in 1 CARTON (63868-081-24) / 12 TABLET, COATED in 1 BLISTER PACK
Packages (1)
Ingredients (3)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2435ad4f-59a9-f2ac-e063-6394a90ae811", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "upc": ["0635515993358"], "unii": ["362O9ITL9D", "495W7451VQ", "04JA59TNSJ"], "rxcui": ["1243679"], "spl_set_id": ["5baa6aab-3959-42ad-b448-a524de81762b"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["Chain Drug Marketing Association"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 BLISTER PACK in 1 CARTON (63868-081-24) / 12 TABLET, COATED in 1 BLISTER PACK", "package_ndc": "63868-081-24", "marketing_end_date": "20260930", "marketing_start_date": "20150930"}], "brand_name": "Severe Cold Head Congestion", "product_id": "63868-081_2435ad4f-59a9-f2ac-e063-6394a90ae811", "dosage_form": "TABLET, COATED", "pharm_class": ["Adrenergic alpha1-Agonists [MoA]", "Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "alpha-1 Adrenergic Agonist [EPC]"], "product_ndc": "63868-081", "generic_name": "ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE", "labeler_name": "Chain Drug Marketing Association", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Severe Cold Head Congestion", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "325 mg/1"}, {"name": "GUAIFENESIN", "strength": "200 mg/1"}, {"name": "PHENYLEPHRINE HYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_end_date": "20260930", "marketing_start_date": "20150930"}